Gustafson P, Akerman M, Alvegård T A, Coindre J-M, Fletcher C D M, Rydholm A, Willén H
Department of Orthopedics, University Hospital, SE-221 85 Lund, Sweden.
Eur J Cancer. 2003 Jul;39(11):1568-76. doi: 10.1016/s0959-8049(03)00369-1.
We have earlier devised a system for soft tissue sarcoma (STS), based on three negative prognostic features: large tumour size, vascular invasion, and microscopic tumour necrosis, the SIN-system. Tumours which exhibit 2 or 3 of these features are categorised as high-risk, the others as low-risk. We have now tested this system for reproducibility both as regards recognition of its components, and as regards prognostic strength in patients from another institution. We have also compared it with the American Joint Committee on Cancer (AJCC) system. 200 patients with STS were analysed, all had been treated by surgery, in 97 patients combined with radiotherapy. The median follow-up for the 117 survivors was 10 (1.5-27) years. Without knowledge of the clinical data, three groups of pathologists independently reviewed original slides from all of the tumours. Based on the factors, the tumours were classified as high-risk or low-risk. The prognostic strength was compared using the results obtained by the different observers. Concordance in recognition of vascular invasion, tumour necrosis, and overall grading was seen in 156 (78%), 154 (77%), and 167 (84%) of the 200 tumours, respectively. Based on the different observers' grading, the cumulative 5-year metastasis-free survival rate (MFSR) varied for patients with low-risk tumours between 0.85 and 0.80, and for patients with high-risk tumours between 0.48 and 0.43. The Kappa-value for grading between all three groups of observers was 0.77. The SIN-system gave more clinically useful prognostic information than the AJCC system. Useful prognostic information in STS can be obtained by using tumour size, vascular invasion and microscopic tumour necrosis. This system provides two distinct prognostic groups, and has a high reproducibility.
肿瘤体积大、血管侵犯和镜下肿瘤坏死,设计了一种软组织肉瘤(STS)系统,即SIN系统。表现出其中2个或3个特征的肿瘤被归类为高风险,其他的则为低风险。我们现在已经对该系统在识别其组成部分以及在另一家机构患者中的预后强度方面的可重复性进行了测试。我们还将其与美国癌症联合委员会(AJCC)系统进行了比较。分析了200例STS患者,所有患者均接受了手术治疗,其中97例患者还接受了放疗。117名幸存者的中位随访时间为10(1.5 - 27)年。在不了解临床数据的情况下,三组病理学家独立审查了所有肿瘤的原始切片。根据这些因素,将肿瘤分类为高风险或低风险。使用不同观察者获得的结果比较预后强度。在200例肿瘤中,分别有156例(78%)、154例(77%)和167例(84%)在血管侵犯、肿瘤坏死和总体分级的识别上具有一致性。根据不同观察者的分级,低风险肿瘤患者的5年无转移生存率(MFSR)在0.85至0.80之间,高风险肿瘤患者的5年无转移生存率在0.48至0.43之间。三组观察者之间分级的Kappa值为0.77。与AJCC系统相比,SIN系统提供了更多具有临床实用性的预后信息。通过使用肿瘤大小、血管侵犯和镜下肿瘤坏死,可以获得STS中有用的预后信息。该系统提供了两个不同的预后组,并且具有很高的可重复性。